SCYNEXIS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCYNEXIS and other ETFs, options, and stocks.

About SCYX

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. 

CEO
David Angulo Gonzalez
CEODavid Angulo Gonzalez
Employees
36
Employees36
Headquarters
Jersey City, New Jersey
HeadquartersJersey City, New Jersey
Founded
1999
Founded1999
Employees
36
Employees36

SCYX Key Statistics

Market cap
55.07M
Market cap55.07M
Price-Earnings ratio
1.09
Price-Earnings ratio1.09
Dividend yield
Dividend yield
Average volume
247.75K
Average volume247.75K
High today
$1.52
High today$1.52
Low today
$1.42
Low today$1.42
Open price
$1.42
Open price$1.42
Volume
148.76K
Volume148.76K
52 Week high
$3.87
52 Week high$3.87
52 Week low
$1.35
52 Week low$1.35
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.